Broadening Horizons with Empagliflozin Back Author: Boehringer Ingelheim Document ID: SC-PH-05666 What’s New in the EMPA-KIDNEY?00:00 SGLT2i Early Foundational Use in T2D32:32 The CKD Blind Spot 56:12